• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用圣托马斯医院心脏停搏液进行长时间主动脉交叉钳夹后的长期生存率。

Long-term survival rates after prolonged aortic cross-clamping with St. Thomas' Hospital cardioplegia.

作者信息

Kyösola K, Chambers D, Canković-Darracott S, Braimbridge M V

机构信息

Cardio-Thoracic Unit, St. Thomas' Hospital, London, U.K.

出版信息

Ann Chir Gynaecol. 1987;76(4):241-2.

PMID:3501691
Abstract

Prolonged aortic cross-clamping (in excess of 120 min) was necessary in 154 cardiac surgical patients. St. Thomas' Hospital cardioplegia was used for myocardial preservation. Quantitative polarization microscopy enabling quantitative birefringence measurements to assess the change in birefringence of the muscle fibres in response to the addition of buffer containing ATP and calcium (i.e. myocardial contractility) was used to detect whether there had been any deterioration in right or left ventricular myocardium during the bypass period. 30 day survival was 90%, long-term (60 months) survival was 80%. In single valve replacements, patients with aortic valvular replacement had 100% survival up to 92 months, whereas patients with mitral valvular replacement had survival rates of 83% after 12 months and 27% after 60 months. Survival rates after 60 months were 89% for coronary artery bypass grafting, 80% for multiple valve replacements, and 74% for combined valvular and coronary artery bypass grafting surgery. Quantitative birefringence assessment of function showed that in the surviving patients 5% had functional deterioration during bypass whereas in the non-surviving patients 70% had functional deterioration. It may be concluded that after cardiac surgery necessitating prolonged aortic cross-clamping--once the initial operative problems are overcome--reasonable long-term results can be obtained by using St. Thomas' Hospital cardioplegia.

摘要

154例心脏外科手术患者需要长时间主动脉交叉钳夹(超过120分钟)。采用圣托马斯医院心脏停搏液进行心肌保护。使用定量偏振显微镜进行定量双折射测量,以评估肌肉纤维双折射随含ATP和钙的缓冲液添加(即心肌收缩力)的变化,来检测体外循环期间右心室或左心室心肌是否出现任何恶化。30天生存率为90%,长期(60个月)生存率为80%。在单瓣膜置换术中,主动脉瓣置换患者92个月内生存率为100%,而二尖瓣置换患者12个月后生存率为83%,60个月后为27%。冠状动脉搭桥术后60个月生存率为89%,多瓣膜置换为80%,瓣膜置换与冠状动脉搭桥联合手术为74%。功能的定量双折射评估显示,存活患者中5%在体外循环期间出现功能恶化,而非存活患者中70%出现功能恶化。可以得出结论,在需要长时间主动脉交叉钳夹的心脏手术后,一旦克服了最初的手术问题,使用圣托马斯医院心脏停搏液可获得合理的长期效果。

相似文献

1
Long-term survival rates after prolonged aortic cross-clamping with St. Thomas' Hospital cardioplegia.采用圣托马斯医院心脏停搏液进行长时间主动脉交叉钳夹后的长期生存率。
Ann Chir Gynaecol. 1987;76(4):241-2.
2
Intermittent aortic cross-clamping versus St. Thomas' Hospital cardioplegia in extensive aorta-coronary bypass grafting. A randomized clinical study.广泛主动脉-冠状动脉搭桥术中间歇性主动脉阻断与圣托马斯医院心脏停搏液的比较:一项随机临床研究
J Thorac Cardiovasc Surg. 1984 Aug;88(2):164-73.
3
Nifedipine as an adjunct to St. Thomas' Hospital cardioplegia. A double-blind, placebo-controlled, randomized clinical trial.硝苯地平作为圣托马斯医院心脏停搏液的辅助药物。一项双盲、安慰剂对照、随机临床试验。
J Thorac Cardiovasc Surg. 1986 May;91(5):723-31.
4
St. Thomas' Hospital cardioplegia for myocardial preservation during prolonged aortic cross-clamping.
Ann Chir Gynaecol. 1985;74(3):111-7.
5
Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.心脏不停跳下的主动脉瓣和二尖瓣手术正在缩短体外循环和主动脉阻断时间。
Heart Surg Forum. 2002;5(2):182-6.
6
Ultrastructural study comparing the efficacy of five different methods of intraoperative myocardial protection in the human heart.比较五种不同术中心肌保护方法对人体心脏疗效的超微结构研究。
J Thorac Cardiovasc Surg. 1986 Jul;92(1):47-55.
7
Clinical and quantitative birefringence assessment of 100 patients with aortic clamping periods in excess of 120 minutes after hypothermic cardioplegic arrest.对100例在低温心脏停搏后主动脉阻断时间超过120分钟的患者进行临床和定量双折射评估。
Thorac Cardiovasc Surg. 1983 Oct;31(5):266-72. doi: 10.1055/s-2007-1021994.
8
[Clinical study on the use of retrograde cardioplegia with St. Thomas' Hospital solution].[使用圣托马斯医院溶液进行逆行性心脏停搏的临床研究]
Kyobu Geka. 1990 May;43(5):342-7; discussion 348-51.
9
Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia--an experimental comparative study in pigs.圣托马斯停搏液和组氨酸-色氨酸-酮戊二酸停搏液诱导心脏停搏后的机械能量功能及肌钙蛋白T释放——猪的实验性对照研究
Interact Cardiovasc Thorac Surg. 2009 Oct;9(4):635-9. doi: 10.1510/icvts.2009.208231. Epub 2009 Jul 23.
10
Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.心肌保护:一种新型镁基心脏停搏液(RS-C)与圣托马斯医院心脏停搏液相比的疗效。
Interact Cardiovasc Thorac Surg. 2008 Oct;7(5):745-9. doi: 10.1510/icvts.2008.181057. Epub 2008 Jun 11.